{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-201578","form_type":"8-K","ticker":"RREV","cik":"0002123969","company_name":"RRE Ventures Acquisition Corp.","filed_at":"2026-05-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.509350+00:00","generated_at":"2026-05-15T00:24:52.982522+00:00","sec_items":["1.01","3.02","5.02","5.03","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"RRE Ventures Acquisition Corp. prices and closes $250M IPO; units begin trading on Nasdaq","bullets":["Priced 25,000,000 units at $10.00 each, gross proceeds of $250M before expenses.","Underwriters granted 45-day option to purchase up to 3,750,000 additional units.","Simultaneous private placement of 7,010,000 warrants at $1.00 each raised $7.01M.","Units trade on Nasdaq under RREVU; Class A shares and warrants expected under RREV and RREVW.","Board appointed: James Gertler, Bruce Bernstein, Dan Galpern, Kendrick Meek, Brian Daly, Robert S. Mancini, and others."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-201578","json":"https://secwatch.observer/filing/0001193125-26-201578.json","markdown":"https://secwatch.observer/filing/0001193125-26-201578.md","text":"https://secwatch.observer/filing/0001193125-26-201578.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2123969/000119312526201578/0001193125-26-201578-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2123969/000119312526201578/d77496d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T00:24:52.982522+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4ee5b6fab4","claim":"Dan Galpern was appointed as Director at RRE Ventures Acquisition Corp..","evidence_excerpt":"James Gertler, Bruce Bernstein, Dan Galpern, Kendrick Meek, Brian Daly and Robert S. Mancini (collectively with Philip Kassin, Jeffrey Douglas Epstein and Stuart Ellman, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/2123969/000119312526201578/0001193125-26-201578-index.htm","confidence":0.95},{"claim_id":"6ab0f4729d","claim":"Brian Daly was appointed as Director at RRE Ventures Acquisition Corp..","evidence_excerpt":"James Gertler, Bruce Bernstein, Dan Galpern, Kendrick Meek, Brian Daly and Robert S. Mancini (collectively with Philip Kassin, Jeffrey Douglas Epstein and Stuart Ellman, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/2123969/000119312526201578/0001193125-26-201578-index.htm","confidence":0.95},{"claim_id":"9fad66bec1","claim":"Bruce Bernstein was appointed as Director at RRE Ventures Acquisition Corp..","evidence_excerpt":"James Gertler, Bruce Bernstein, Dan Galpern, Kendrick Meek, Brian Daly and Robert S. Mancini (collectively with Philip Kassin, Jeffrey Douglas Epstein and Stuart Ellman, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/2123969/000119312526201578/0001193125-26-201578-index.htm","confidence":0.95},{"claim_id":"c139add5fb","claim":"James Gertler was appointed as Director at RRE Ventures Acquisition Corp..","evidence_excerpt":"James Gertler, Bruce Bernstein, Dan Galpern, Kendrick Meek, Brian Daly and Robert S. Mancini (collectively with Philip Kassin, Jeffrey Douglas Epstein and Stuart Ellman, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/2123969/000119312526201578/0001193125-26-201578-index.htm","confidence":0.95},{"claim_id":"cc52cb425e","claim":"Robert S. Mancini was appointed as Director at RRE Ventures Acquisition Corp..","evidence_excerpt":"James Gertler, Bruce Bernstein, Dan Galpern, Kendrick Meek, Brian Daly and Robert S. Mancini (collectively with Philip Kassin, Jeffrey Douglas Epstein and Stuart Ellman, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/2123969/000119312526201578/0001193125-26-201578-index.htm","confidence":0.95},{"claim_id":"f442518f35","claim":"Kendrick Meek was appointed as Director at RRE Ventures Acquisition Corp..","evidence_excerpt":"James Gertler, Bruce Bernstein, Dan Galpern, Kendrick Meek, Brian Daly and Robert S. Mancini (collectively with Philip Kassin, Jeffrey Douglas Epstein and Stuart Ellman, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/2123969/000119312526201578/0001193125-26-201578-index.htm","confidence":0.95},{"claim_id":"a244c9f5fb6c9a1a997fe739ce0c4cbabad86951","claim":"RRE Ventures Acquisition Corp.: Amended and restated memorandum and articles of association filed in connection with IPO (effective 2026-04-29).","evidence_excerpt":"On April 28, 2026, in connection with the IPO, the Company filed its amended and restated memorandum and articles of association (the “ Amended and Restated Memorandum and Articles of Association ”) with the Cayman Islands Registrar of Companies, which was effective on April 29, 2026.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/2123969/000119312526201578/0001193125-26-201578-index.htm","confidence":0.9},{"claim_id":"5f53886fa5786596c048504893554fc75432329d","claim":"RRE Ventures Acquisition Corp. entered into Underwriting Agreement with Cohen & Company Capital Markets, a division of Cohen & Company Securities, LLC, as representative of the several underwriters (effective 2026-04-29).","evidence_excerpt":"On April 29, 2026, RRE Ventures Acquisition Corp. (the “ Company ”) entered into an Underwriting Agreement (the “ Underwriting Agreement ”) with Cohen & Company Capital Markets, a division of Cohen & Company Securities, LLC (“ Cohen ”), as representative of the several underwriters (the “ Underwriters ”), relating to the initial public offering (“ IPO ”) of the Company’s units (the “ Public Units ”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/2123969/000119312526201578/0001193125-26-201578-index.htm","confidence":0.99}],"comparable_filings":[{"accession":"0001185185-26-002273","ticker":"DGAC","company_name":"DISCIPLINED GROWTH ACQUISITION Corp","filed_at":"2026-06-01T20:15:34+00:00","headline":"Disciplined Growth Acquisition Corp. closes $150M IPO on NYSE","event_type":"other_material","sec_items":["1.01","3.02","5.02","5.03","8.01","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same fact type: executive_change, governance_change, material_agreement","same SEC item: 1.01, 3.02, 5.02, 5.03, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001185185-26-002273","json":"https://secwatch.observer/filing/0001185185-26-002273.json","markdown":"https://secwatch.observer/filing/0001185185-26-002273.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2111038/000118518526002273/0001185185-26-002273-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2111038/000118518526002273/dgac8k052926.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"James Gertler, Bruce Bernstein, Dan Galpern, Kendrick Meek, Brian Daly and Robert S. Mancini (collectively with Philip Kassin, Jeffrey Douglas Epstein and Stuart Ellman, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/2123969/000119312526201578/0001193125-26-201578-index.htm","comparable_excerpt":"John W. Heilshorn, Aaron Spool, Michael Faber, John Ziegelman and Jay Gettenberg (collectively, the “Directors”) were appointed to the board of directors of the Company (the “Board”).","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2111038/000118518526002273/0001185185-26-002273-index.htm"}},{"accession":"0001104659-26-068521","ticker":"FDXF","company_name":"FedEx Freight Holding Company, Inc.","filed_at":"2026-06-01T10:46:03+00:00","headline":"FedEx Freight completes spin-off from FedEx; $600M drawn, new board and executives appointed","event_type":"other_material","sec_items":["1.01","2.03","3.03","5.03","5.01","5.02","5.05","8.01","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same fact type: executive_change","same SEC item: 1.01, 5.02, 5.03, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-068521","json":"https://secwatch.observer/filing/0001104659-26-068521.json","markdown":"https://secwatch.observer/filing/0001104659-26-068521.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2082247/000110465926068521/0001104659-26-068521-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2082247/000110465926068521/tm2615735d2_8k.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"James Gertler, Bruce Bernstein, Dan Galpern, Kendrick Meek, Brian Daly and Robert S. Mancini (collectively with Philip Kassin, Jeffrey Douglas Epstein and Stuart Ellman, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/2123969/000119312526201578/0001193125-26-201578-index.htm","comparable_excerpt":"each of John A. Smith, R. Brad Martin, Jeffrey A. Davis, Donald E. Frieson, Stephen E. Gorman, Robert A. King, Cindy J. Miller, Amy J. Salcido, and Samantha M. Smith was appointed to the Board","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2082247/000110465926068521/0001104659-26-068521-index.htm"}},{"accession":"0001829126-26-005831","ticker":"FXAC","company_name":"FortuneX Acquisition Corp","filed_at":"2026-05-29T21:32:49+00:00","headline":"FortuneX Acquisition closes IPO of 8.625M units at $10/unit, raising $86.25M gross","event_type":"other_material","sec_items":["1.01","3.02","5.02","5.03","9.01"],"materiality_score":0.8,"calibrated_materiality_score":0.8,"match_reasons":["same fact type: executive_change","same SEC item: 1.01, 3.02, 5.02, 5.03, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-26-005831","json":"https://secwatch.observer/filing/0001829126-26-005831.json","markdown":"https://secwatch.observer/filing/0001829126-26-005831.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2121703/000182912626005831/0001829126-26-005831-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2121703/000182912626005831/fortunexacq_8k.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"James Gertler, Bruce Bernstein, Dan Galpern, Kendrick Meek, Brian Daly and Robert S. Mancini (collectively with Philip Kassin, Jeffrey Douglas Epstein and Stuart Ellman, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/2123969/000119312526201578/0001193125-26-201578-index.htm","comparable_excerpt":"Effective May 19, 2026, in connection with the effectiveness of the Company’s Registration Statement, Becky Fallon, Sean Michael Deegan, and Robert Labbe became members of the board of directors (the “Board”) of the Company.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2121703/000182912626005831/0001829126-26-005831-index.htm"}},{"accession":"0001193125-26-249692","ticker":"ELOX","company_name":"Eloxx Pharmaceuticals, Inc.","filed_at":"2026-06-01T11:00:19+00:00","headline":"Eloxx Pharma: 1-for-11 reverse stock split effective May 29; appoints two independent directors","event_type":"other_material","sec_items":["3.02","3.03","5.03","5.02","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same fact type: executive_change","same SEC item: 3.02, 5.02, 5.03, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-249692","json":"https://secwatch.observer/filing/0001193125-26-249692.json","markdown":"https://secwatch.observer/filing/0001193125-26-249692.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1035354/000119312526249692/0001193125-26-249692-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1035354/000119312526249692/d261568d8k.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"James Gertler, Bruce Bernstein, Dan Galpern, Kendrick Meek, Brian Daly and Robert S. Mancini (collectively with Philip Kassin, Jeffrey Douglas Epstein and Stuart Ellman, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/2123969/000119312526201578/0001193125-26-201578-index.htm","comparable_excerpt":"the Board of Directors (the “Board”) of Eloxx Pharmaceuticals, Inc. (the “Company”) appointed Stephen W. Webster and Nina Kjellson to fill vacancies on the Board","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1035354/000119312526249692/0001193125-26-249692-index.htm"}},{"accession":"0001750155-26-000080","ticker":"CWBHF","company_name":"Charlotte's Web Holdings, Inc.","filed_at":"2026-06-01T21:13:23+00:00","headline":"Charlotte's Web appoints BAT GC to board, closes debt conversion & US$10M investment","event_type":"other_material","sec_items":["5.02","5.07","8.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same fact type: executive_change","same SEC item: 5.02, 8.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001750155-26-000080","json":"https://secwatch.observer/filing/0001750155-26-000080.json","markdown":"https://secwatch.observer/filing/0001750155-26-000080.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1750155/000175015526000080/0001750155-26-000080-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1750155/000175015526000080/cweb-20260528.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"James Gertler, Bruce Bernstein, Dan Galpern, Kendrick Meek, Brian Daly and Robert S. Mancini (collectively with Philip Kassin, Jeffrey Douglas Epstein and Stuart Ellman, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/2123969/000119312526201578/0001193125-26-201578-index.htm","comparable_excerpt":"Effective May 28, 2026 (the “Effective Date”), the board of directors of Charlotte’s Web Holdings, Inc. (the “Company”), appoint James Jeffery Raborn to the Company’s board of directors","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1750155/000175015526000080/0001750155-26-000080-index.htm"}},{"accession":"0001493152-26-026544","ticker":"LIXT","company_name":"LIXTE BIOTECHNOLOGY HOLDINGS, INC.","filed_at":"2026-06-01T12:55:34+00:00","headline":"Lixte Biotechnology pivots to AI energy infrastructure; appoints Denham Capital founder to board","event_type":"other_material","sec_items":["5.02","7.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same fact type: executive_change","same SEC item: 5.02, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-026544","json":"https://secwatch.observer/filing/0001493152-26-026544.json","markdown":"https://secwatch.observer/filing/0001493152-26-026544.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1335105/000149315226026544/0001493152-26-026544-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1335105/000149315226026544/form8-k.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"James Gertler, Bruce Bernstein, Dan Galpern, Kendrick Meek, Brian Daly and Robert S. Mancini (collectively with Philip Kassin, Jeffrey Douglas Epstein and Stuart Ellman, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/2123969/000119312526201578/0001193125-26-201578-index.htm","comparable_excerpt":"On May 29, 2026, the Board of Directors (the “Board”) of Lixte Biotechnology Holdings, Inc., (the “Company”), appointed Stuart D. Porter to serve as a member of the Board, effective May 29, 2026 with a term expiring at the Company’s 2026 Annual Meeting of Stockholders.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1335105/000149315226026544/0001493152-26-026544-index.htm"}},{"accession":"0001437749-26-018930","ticker":"CPSH","company_name":"CPS TECHNOLOGIES CORP/DE/","filed_at":"2026-06-01T13:35:50+00:00","headline":"CPS Technologies closes $9.6M registered direct offering of 1.2M shares at $8.00/share","event_type":"other_material","sec_items":["1.01","5.03","8.01","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same fact type: governance_change, material_agreement","same SEC item: 1.01, 5.03, 8.01, 9.01","same event type: other_material"],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-018930","json":"https://secwatch.observer/filing/0001437749-26-018930.json","markdown":"https://secwatch.observer/filing/0001437749-26-018930.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/814676/000143774926018930/0001437749-26-018930-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/814676/000143774926018930/cpsh20260528_8k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On April 28, 2026, in connection with the IPO, the Company filed its amended and restated memorandum and articles of association (the “ Amended and Restated Memorandum and Articles of Association ”) with the Cayman Islands Registrar of Companies, which was effective on April 29, 2026.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/2123969/000119312526201578/0001193125-26-201578-index.htm","comparable_excerpt":"On May 27, 2026, the Company filed with the Secretary of State of the State of Delaware a Certificate of Amendment (the “Amendment”) of the Company’s Restated Certificate of Incorporation, effective as of the same date. The Amendment increased the number of shares of common stock, $0.01 par value per share (the “Common Stock”), that the Company is authorized to issue from 20,000,000 to 25,000,000.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/814676/000143774926018930/0001437749-26-018930-index.htm"}},{"accession":"0001171843-26-003809","ticker":"CRMT","company_name":"AMERICAS CARMART INC","filed_at":"2026-05-29T21:30:17+00:00","headline":"America's Car-Mart forms special committee for strategic alternatives; appoints new independent director","event_type":"other_material","sec_items":["1.01","5.02","8.01","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same fact type: executive_change","same SEC item: 1.01, 5.02, 8.01, 9.01","same event type: other_material"],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-26-003809","json":"https://secwatch.observer/filing/0001171843-26-003809.json","markdown":"https://secwatch.observer/filing/0001171843-26-003809.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/799850/000117184326003809/0001171843-26-003809-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/799850/000117184326003809/f8k_052926.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"James Gertler, Bruce Bernstein, Dan Galpern, Kendrick Meek, Brian Daly and Robert S. Mancini (collectively with Philip Kassin, Jeffrey Douglas Epstein and Stuart Ellman, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/2123969/000119312526201578/0001193125-26-201578-index.htm","comparable_excerpt":"On May 22, 2026, the Board increased the size of the Board from nine members to ten members and appointed Adam Paul as an independent director, effective immediately.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/799850/000117184326003809/0001171843-26-003809-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}